34.78
price up icon0.38%   0.134
 
loading
전일 마감가:
$34.65
열려 있는:
$34.75
하루 거래량:
338.53K
Relative Volume:
0.17
시가총액:
$9.84B
수익:
$2.08B
순이익/손실:
$466.92M
주가수익비율:
122.78
EPS:
0.2833
순현금흐름:
$404.94M
1주 성능:
-0.77%
1개월 성능:
+21.35%
6개월 성능:
+65.46%
1년 성능:
+63.90%
1일 변동 폭
Value
$34.40
$34.91
1주일 범위
Value
$33.82
$35.13
52주 변동 폭
Value
$19.20
$36.60

Exelixis Inc Stock (EXEL) Company Profile

Name
명칭
Exelixis Inc
Name
전화
(650) 837-7000
Name
주소
1851 HARBOR BAY PARKWAY, ALAMEDA, CA
Name
직원
1,310
Name
트위터
@exelixisinc
Name
다음 수익 날짜
2024-10-29
Name
최신 SEC 제출 서류
Name
EXEL's Discussions on Twitter

EXEL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
EXEL 34.78 9.84B 2.08B 466.92M 404.94M 0.2833
VRTX 449.26 115.74B 10.63B -479.80M -1.35B 13.33
REGN 747.10 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.38 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.29 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.94 24.49B 3.30B -501.07M 1.03B 11.54

Exelixis Inc Stock (EXEL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-19 개시 BTIG Research Buy
2023-12-15 개시 Citigroup Buy
2023-09-26 개시 H.C. Wainwright Buy
2023-08-22 재확인 Oppenheimer Outperform
2023-08-08 개시 SVB Securities Market Perform
2023-07-11 재개 Morgan Stanley Equal-Weight
2023-05-10 재개 Piper Sandler Overweight
2023-03-09 개시 Wells Fargo Overweight
2023-01-26 개시 Credit Suisse Outperform
2022-10-18 개시 JMP Securities Mkt Outperform
2022-06-24 개시 BMO Capital Markets Outperform
2021-11-19 개시 Piper Sandler Overweight
2021-11-03 재개 Jefferies Buy
2021-10-07 개시 Jefferies Buy
2021-08-06 재확인 H.C. Wainwright Buy
2021-06-15 개시 H.C. Wainwright Buy
2021-05-18 재개 Goldman Sell
2021-03-31 개시 Credit Suisse Outperform
2021-03-12 개시 Wolfe Research Outperform
2020-03-04 개시 Barclays Overweight
2020-01-13 개시 SunTrust Buy
2019-11-13 개시 BofA/Merrill Buy
2019-03-18 업그레이드 Morgan Stanley Underweight → Equal-Weight
2018-09-17 개시 Goldman Neutral
2018-09-10 개시 Morgan Stanley Underweight
2018-05-11 재확인 Needham Buy
2017-10-17 재확인 Needham Buy
2017-10-17 재확인 RBC Capital Mkts Outperform
2017-10-16 재확인 SunTrust Buy
2017-09-22 다운그레이드 Leerink Partners Outperform → Mkt Perform
2017-09-15 개시 RBC Capital Mkts Outperform
2017-09-12 재확인 Needham Buy
2017-07-14 개시 SunTrust Buy
2017-03-31 개시 Needham Buy
2017-03-16 개시 Oppenheimer Perform
2017-02-28 다운그레이드 Stifel Buy → Hold
2016-11-03 개시 Deutsche Bank Buy
2016-10-10 업그레이드 Piper Jaffray Neutral → Overweight
2016-09-15 재확인 Stifel Buy
모두보기

Exelixis Inc 주식(EXEL)의 최신 뉴스

pulisher
06:10 AM

Ontario Teachers Pension Plan Board Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

06:10 AM
pulisher
Nov 20, 2024

EULAV Asset Management Sells 45,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Thyroid Cancer Therapeutics Market May See a Big Move| Pfizer, Exelixis, AbbVie - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Exelixis exec Haley Patrick sells $1.43 million in stock By Investing.com - Investing.com Australia

Nov 19, 2024
pulisher
Nov 19, 2024

Exelixis exec Haley Patrick sells $1.43 million in stock - Investing.com

Nov 19, 2024
pulisher
Nov 18, 2024

Janney Montgomery Scott LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Exelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Seizert Capital Partners LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

1 No-Brainer Stock to Buy With $40 - AOL

Nov 17, 2024
pulisher
Nov 16, 2024

Cornercap Investment Counsel Inc. Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

18,300 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Entropy Technologies LP - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Exelixis, Inc. (NASDAQ:EXEL) Receives $31.44 Consensus Target Price from Analysts - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Principal Financial Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 15, 2024
pulisher
Nov 13, 2024

Here's Why Exelixis (EXEL) is a Strong Momentum Stock - MSN

Nov 13, 2024
pulisher
Nov 12, 2024

CWA Asset Management Group LLC Invests $577,000 in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Here's Why Exelixis (EXEL) is a Strong Value Stock - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now? - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Here is Why Growth Investors Should Buy Exelixis (EXEL) Now - MSN

Nov 11, 2024
pulisher
Nov 10, 2024

Los Angeles Capital Management LLC Has $46.47 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Van ECK Associates Corp Boosts Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Have Insiders Sold Exelixis Shares Recently? - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Exelixis CSO Aftab Dana sells $3.39 million in stock - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

Exelixis CSO Aftab Dana sells $3.39 million in stock By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Exelixis to shed 212K sf of industrial in Alameda - The Real Deal

Nov 07, 2024
pulisher
Nov 07, 2024

Robeco Institutional Asset Management B.V. Purchases 350,026 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Exelixis stock soars to 52-week high, reaches $35.76 - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Exelixis's SWOT analysis: oncology leader's stock poised for growth By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Exelixis EVP sells $1.7 million in stock - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis EVP sells $1.7 million in stock By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis director George Poste sells $1.02 million in shares - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis director George Poste sells $1.02 million in shares By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Earnings Estimates Rising for Exelixis (EXEL): Will It Gain? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis (NASDAQ:EXEL) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Capital Management Corp VA - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis's SWOT analysis: oncology leader's stock poised for growth - Investing.com India

Nov 05, 2024
pulisher
Nov 04, 2024

Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Exelixis (EXEL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Nov 04, 2024
pulisher
Nov 03, 2024

3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool

Nov 03, 2024
pulisher
Nov 03, 2024

New York State Teachers Retirement System Purchases 20,008 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Dana Aftab Sells 1,162 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis (NASDAQ:EXEL) Issues Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Trend Tracker for (EXEL) - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis price target raised to $38 from $33 at Truist - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Stephens Investment Management Group LLC Has $98.78 Million Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis stock hits 52-week high at $31.3 amid robust growth - Investing.com Australia

Oct 31, 2024

Exelixis Inc (EXEL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):